2.1 Å crystal structure of the Mycobacterium tuberculosis serine hydrolase, Hip1, in its anhydro-form (Anhydrohip1).

[1]  M. Bogyo,et al.  Chemiluminescent Protease Probe for Rapid, Sensitive, and Inexpensive Detection of Live Mycobacterium tuberculosis , 2021, ACS central science.

[2]  P. Cos,et al.  Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy , 2019, International journal of molecular sciences.

[3]  Wei Tian,et al.  CASTp 3.0: computed atlas of surface topography of proteins , 2018, Nucleic Acids Res..

[4]  Thomas R. Ioerger,et al.  Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis , 2017, Antimicrobial Agents and Chemotherapy.

[5]  G. Petsko,et al.  Structure Determination of Mycobacterium tuberculosis Serine Protease Hip1 (Rv2224c). , 2017, Biochemistry.

[6]  M. Bogyo,et al.  Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis , 2016, ACS infectious diseases.

[7]  G. Petsko,et al.  Mycobacterium tuberculosis Hip1 Modulates Macrophage Responses through Proteolysis of GroEL2 , 2014, PLoS pathogens.

[8]  Shinichi Ishii,et al.  A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. , 2013, Biochemical and biophysical research communications.

[9]  Hong Cao,et al.  The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors , 2012, PLoS pathogens.

[10]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[11]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[12]  D. Schnappinger,et al.  Acid-Susceptible Mutants of Mycobacterium tuberculosis Share Hypersusceptibility to Cell Wall and Oxidative Stress and to the Host Environment , 2008, Journal of bacteriology.

[13]  D. Schnappinger,et al.  A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis , 2008, Nature Medicine.

[14]  L. Glimcher,et al.  Mycobacterium tuberculosis Rv2224c modulates innate immune responses , 2008, Proceedings of the National Academy of Sciences.

[15]  W. Bishai,et al.  Characterization of a Novel Cell Wall-anchored Protein with Carboxylesterase Activity Required for Virulence in Mycobacterium tuberculosis* , 2007, Journal of Biological Chemistry.

[16]  R. Parker,et al.  Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. , 2005, Journal of medicinal chemistry.

[17]  E. Rubin,et al.  Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[19]  Thomas M Frimurer,et al.  Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities. , 2003, Biophysical journal.

[20]  I. Smith,et al.  Mycobacterium tuberculosis Genes Induced during Infection of Human Macrophages , 2002, Infection and Immunity.

[21]  T. Koide,et al.  Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates. , 2001, The Biochemical journal.

[22]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[23]  J. Powers,et al.  Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. , 1991, Biochemistry.

[24]  J. Powers,et al.  Selective isocoumarin serine protease inhibitors block RNK-16 lymphocyte granule-mediated cytolysis. , 1989, Molecular immunology.

[25]  W. Kabsch.  A solution for the best rotation to relate two sets of vectors , 1976 .

[26]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[27]  D. Koshland,et al.  The formation of anhydrochymotrypsin by removing the elements of water from the serine at the active site. , 1966, Journal of the American Chemical Society.

[28]  A. Gold,et al.  SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. II. FORMATION AND REACTIONS OF PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN. , 1964, Biochemistry.

[29]  I. Photaki.  Transformation of Serine to Cysteine. β-Elimination Reactions in Serine Derivatives , 1963 .

[30]  Howard L. Saft,et al.  Active site specificity of plasmepsin II , 1999, Protein science : a publication of the Protein Society.

[31]  W. Lawson,et al.  Studies on the inhibition of human thrombin: effects of plasma and plasma constituents. , 1982, Folia haematologica.